IRB Receives Successful Audit From FDA

Congratulations to the Internal Review Board (IRB) for receiving a successful audit and accolades from the FDA.

The auditor reported that there were no deviations from regulations that needed to be addressed. The auditor also complimented the IRB staff and committee members on the good job that they are doing.

Special thanks go to Kathleen Montgomery, IRB Manager; and David P. Warshal, MD, Chair of the IRB, Vice Chief of the Department of Obstetrics and Gynecology, Head of the Division of Gynecologic Oncology and Director of the Gynecologic Cancer Center, for all of their hard work in making this audit a success.

Comments are closed, but trackbacks and pingbacks are open.